Diffuse pain, hypophosphatemia, and a subcutaneous nodule

Journal of the American Academy of Dermatology

Volumn 57, Issue 3, 2007, Pages 509-512

  DeWitt, Christine A ^a   Collins, Michael T ^b   Cowen, Edward W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PHOSPHORUS;

ADULT; ARTICLE; CASE REPORT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPOPHOSPHATEMIA; KYPHOSIS; LABORATORY TEST; MALE; MESENCHYMOMA; MUSCLE STRENGTH; OSTEOMALACIA; PAIN; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPINDLE CELL; SUBCUTANEOUS NODULE; THORAX DEFORMITY; TREATMENT OUTCOME; WEAKNESS;

HUMANS; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIA, FAMILIAL; MALE; MESENCHYMOMA; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; OSTEOMALACIA; PAIN; SUBCUTANEOUS TISSUE;

EID: 34547818072     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.05.010     Document Type: Article

References (14)

1. Weidner N., and Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59 (1987) 1442-1454
2. Collins M.T., Chebli C., Jones J., Kushner H., Consugar M., Rinaldo P., et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16 (2001) 806-813
3. Imel E.A., and Econs M.J. Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol 16 (2005) 2565-2575
4. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26 (2000) 345-348
5. Jonsson K.B., Zahradnik R., Larsson T., White K.E., Sugimoto T., Imanishi Y., et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348 (2003) 1656-1663
6. Feng J.Q., Ward L.M., Liu S., Lu Y., Xie Y., Yuan B., et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38 (2006) 1310-1315
7. Riminucci M., Collins M.T., Fedarko N.S., Cherman N., Corsi A., White K.E., et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112 (2003) 683-692
8. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98 (2001) 6500-6505
9. Folpe A.L., Fanburg-Smith J.C., Billings S.D., Bisceglia M., Bertoni F., Cho J.Y., et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28 (2004) 1-30
10. Cheung F.M., Ma L., Wu W.C., Siu T.H., Choi P.T., and Tai Y.P. Oncogenic osteomalacia associated with an occult phosphaturic mesenchymal tumour: clinico-radiologico-pathological correlation and ultrastructural studies. Hong Kong Med J 12 (2006) 319-321
11. Sundaram M., and McCarthy E.F. Oncogenic osteomalacia. Skeletal Radiol 29 (2000) 117-124
12. Fletcher C.D. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48 (2006) 3-12
13. Jan de Beur S.M. Tumor-induced osteomalacia. JAMA 294 (2005) 1260-1267
14. Takeuchi Y., Suzuki H., Ogura S., Imai R., Yamazaki Y., Yamashita T., et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89 (2004) 3979-3982